A long waiting period for critical equipment and a 50% hike in the cost of APIs imported from China are among the immediate challenges
Revlimid is a blood cancer drug with sales of US $ 12.1 billion in 2020
In his previous assignment Perfetti was associated with Fabbrica Italiana Sintetici (F.I.S) as Chief Commercial Officer
Labetalol hydrochloride injection USP is indicated for the control of blood pressure in severe hypertension.
Ind-Ra expects IPM revenue to grow over 12% YoY in FY22
As of FY21, it is the largest independent medical device company and the second-largest company overall, in the surgical consumables market in India with a 7.91 per cent share based on the value
The DGTR has recommended US $ 3.2 per kg and US $ 3.55 per kg duty on imports
The global CRAMS segment is expected to clock 6.2% CAGR over CY21-26E to touch US $ 170 billion
The investment is part of the group's digital health initiatives, to foster affordable access to world-class technology and an innovation-led healthcare ecosystem in India
In March 2016, Dr. Reddy’s had acquired the exclusive global rights (excluding Japan and Asia) to the investigational anti-cancer agent E7777 from Eisai Co.
Subscribe To Our Newsletter & Stay Updated
